Annual Shareholders Equity
$10.90 B
-$2.95 B-21.32%
December 31, 2024
Summary
- As of February 20, 2025, MRNA annual stockholders equity is $10.90 billion, with the most recent change of -$2.95 billion (-21.32%) on December 31, 2024.
- During the last 3 years, MRNA annual shareholders equity has fallen by -$3.24 billion (-22.93%).
- MRNA annual shareholders equity is now -43.00% below its all-time high of $19.12 billion, reached on December 31, 2022.
Performance
MRNA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$10.90 B
-$1.03 B-8.60%
December 31, 2024
Summary
- As of February 20, 2025, MRNA quarterly stockholders equity is $10.90 billion, with the most recent change of -$1.03 billion (-8.60%) on December 31, 2024.
- Over the past year, MRNA quarterly shareholders equity has dropped by -$2.95 billion (-21.32%).
- MRNA quarterly shareholders equity is now -43.00% below its all-time high of $19.12 billion, reached on December 31, 2022.
Performance
MRNA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MRNA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.3% | -21.3% |
| 3 y3 years | -22.9% | -21.3% |
| 5 y5 years | +827.9% | -21.3% |
MRNA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.0% | at low | -43.0% | at low |
| 5 y | 5-year | -43.0% | +827.9% | -43.0% | +827.9% |
| alltime | all time | -43.0% | >+9999.0% | -43.0% | >+9999.0% |
Moderna Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $10.90 B(-21.3%) | $10.90 B(-8.6%) |
| Sep 2024 | - | $11.93 B(+1.8%) |
| Jun 2024 | - | $11.71 B(-8.6%) |
| Mar 2024 | - | $12.82 B(-7.5%) |
| Dec 2023 | $13.85 B(-27.6%) | $13.85 B(+3.0%) |
| Sep 2023 | - | $13.46 B(-20.6%) |
| Jun 2023 | - | $16.95 B(-10.1%) |
| Mar 2023 | - | $18.86 B(-1.4%) |
| Dec 2022 | $19.12 B(+35.2%) | $19.12 B(+6.3%) |
| Sep 2022 | - | $17.99 B(+0.0%) |
| Jun 2022 | - | $17.98 B(+5.3%) |
| Mar 2022 | - | $17.07 B(+20.7%) |
| Dec 2021 | $14.14 B(+452.3%) | $14.14 B(+39.7%) |
| Sep 2021 | - | $10.12 B(+51.0%) |
| Jun 2021 | - | $6.70 B(+74.7%) |
| Mar 2021 | - | $3.84 B(+49.9%) |
| Dec 2020 | $2.56 B(+118.0%) | $2.56 B(-7.2%) |
| Sep 2020 | - | $2.76 B(-6.3%) |
| Jun 2020 | - | $2.95 B(+79.6%) |
| Mar 2020 | - | $1.64 B(+39.7%) |
| Dec 2019 | $1.17 B(-23.2%) | $1.17 B(-6.2%) |
| Sep 2019 | - | $1.25 B(-6.5%) |
| Jun 2019 | - | $1.34 B(-7.4%) |
| Mar 2019 | - | $1.45 B(-5.5%) |
| Dec 2018 | $1.53 B(+144.7%) | $1.53 B(+42.2%) |
| Sep 2018 | - | $1.08 B(+8773.8%) |
| Jun 2018 | - | $12.13 M(-1627.8%) |
| Mar 2018 | - | -$794.00 K(-100.1%) |
| Dec 2017 | $625.30 M(-25.7%) | $625.30 M(>+9900.0%) |
| Sep 2017 | - | $1.63 M(-34.1%) |
| Jun 2017 | - | $2.47 M(-27.6%) |
| Mar 2017 | - | $3.42 M(+6.2%) |
| Dec 2016 | $841.85 M(>+9900.0%) | - |
| Dec 2016 | - | $3.22 M(+129.4%) |
| Sep 2016 | - | $1.40 M(+30.5%) |
| Jun 2016 | - | $1.07 M(-27.7%) |
| Mar 2016 | - | $1.49 M(+465.0%) |
| Dec 2015 | $263.00 K(-106.0%) | $263.00 K(-165.8%) |
| Sep 2015 | - | -$400.00 K(-84.0%) |
| Jun 2015 | - | -$2.50 M(-31.7%) |
| Mar 2015 | - | -$3.65 M(-16.5%) |
| Dec 2014 | -$4.37 M(-38.1%) | -$4.37 M(-57.1%) |
| Sep 2014 | - | -$10.19 M(+206.1%) |
| Jun 2014 | - | -$3.33 M(-54.4%) |
| Mar 2014 | - | -$7.30 M(+3.3%) |
| Dec 2013 | -$7.06 M(+25.5%) | -$7.06 M(+37.4%) |
| Sep 2013 | - | -$5.14 M(+22.4%) |
| Jun 2013 | - | -$4.20 M(-0.5%) |
| Mar 2013 | - | -$4.22 M(-25.0%) |
| Dec 2012 | -$5.63 M(<-9900.0%) | -$5.63 M(+139.5%) |
| Sep 2012 | - | -$2.35 M(+27.0%) |
| Jun 2012 | - | -$1.85 M(-44.5%) |
| Mar 2012 | - | -$3.34 M(-8881.6%) |
| Dec 2011 | $38.00 K(-99.8%) | $38.00 K(-99.8%) |
| Sep 2011 | - | $15.88 M(-2.7%) |
| Jun 2011 | - | $16.32 M(-15.4%) |
| Mar 2011 | - | $19.28 M(+12.3%) |
| Dec 2010 | $17.17 M(-349.3%) | $17.17 M(-349.3%) |
| Sep 2010 | - | -$6.89 M(-47.8%) |
| Jun 2010 | - | -$13.20 M(+38.6%) |
| Mar 2010 | - | -$9.52 M(+38.3%) |
| Dec 2009 | -$6.89 M | -$6.89 M(+3.8%) |
| Sep 2009 | - | -$6.64 M(+596.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | -$953.00 K(-123.2%) |
| Mar 2009 | - | $4.11 M(-226.2%) |
| Dec 2008 | -$3.26 M(-108.3%) | -$3.26 M(-161.2%) |
| Sep 2008 | - | $5.32 M(-71.1%) |
| Jun 2008 | - | $18.45 M(-23.5%) |
| Mar 2008 | - | $24.12 M(-38.5%) |
| Dec 2007 | $39.22 M(-9.5%) | $39.22 M(-21.2%) |
| Sep 2007 | - | $49.74 M(-21.5%) |
| Jun 2007 | - | $63.40 M(-14.8%) |
| Mar 2007 | - | $74.38 M(+71.6%) |
| Dec 2006 | $43.34 M(-22.0%) | $43.34 M(-15.9%) |
| Sep 2006 | - | $51.51 M(-11.0%) |
| Jun 2006 | - | $57.86 M(+2.5%) |
| Mar 2006 | - | $56.44 M(+1.6%) |
| Dec 2005 | $55.57 M(-4.4%) | $55.57 M(-12.0%) |
| Sep 2005 | - | $63.17 M(+38.4%) |
| Jun 2005 | - | $45.66 M(-12.9%) |
| Mar 2005 | - | $52.42 M(-9.8%) |
| Dec 2004 | $58.15 M(+224.7%) | $58.15 M(+510.5%) |
| Sep 2004 | - | $9.52 M(-42.3%) |
| Jun 2004 | - | $16.50 M(+51.1%) |
| Mar 2004 | - | $10.92 M(-39.0%) |
| Dec 2003 | $17.91 M(+107.1%) | $17.91 M(-23.7%) |
| Sep 2003 | - | $23.47 M(+20.8%) |
| Jun 2003 | - | $19.43 M(+231.8%) |
| Mar 2003 | - | $5.86 M(-32.3%) |
| Dec 2002 | $8.64 M(-35.9%) | $8.64 M(-36.8%) |
| Sep 2002 | - | $13.69 M(-18.0%) |
| Jun 2002 | - | $16.69 M(-1.8%) |
| Mar 2002 | - | $17.00 M(+26.0%) |
| Dec 2001 | $13.49 M(+41.1%) | $13.49 M(+40.2%) |
| Sep 2001 | - | $9.63 M(-5.3%) |
| Jun 2001 | - | $10.16 M(-11.1%) |
| Mar 2001 | - | $11.43 M(+19.5%) |
| Dec 2000 | $9.56 M(-42.4%) | $9.56 M(-11.7%) |
| Sep 2000 | - | $10.83 M(-11.2%) |
| Jun 2000 | - | $12.19 M(-15.6%) |
| Mar 2000 | - | $14.45 M(-12.9%) |
| Dec 1999 | $16.60 M(-34.9%) | $16.60 M(-14.9%) |
| Sep 1999 | - | $19.50 M(-11.0%) |
| Jun 1999 | - | $21.90 M(-6.0%) |
| Mar 1999 | - | $23.30 M(-8.6%) |
| Dec 1998 | $25.50 M(+2.4%) | $25.50 M(-4.5%) |
| Sep 1998 | - | $26.70 M(-0.7%) |
| Jun 1998 | - | $26.90 M(+6.3%) |
| Mar 1998 | - | $25.30 M(+1.6%) |
| Dec 1997 | $24.90 M(+111.0%) | $24.90 M(-6.7%) |
| Sep 1997 | - | $26.70 M(-4.6%) |
| Jun 1997 | - | $28.00 M(-3.1%) |
| Mar 1997 | - | $28.90 M(+265.8%) |
| Dec 1996 | $11.80 M(+55.3%) | - |
| Sep 1996 | - | $7.90 M(+3.9%) |
| Jun 1996 | $7.60 M(0.0%) | $7.60 M(+76.7%) |
| Mar 1996 | - | $4.30 M(+4.9%) |
| Dec 1995 | - | $4.10 M(-4.7%) |
| Sep 1995 | - | $4.30 M(-43.4%) |
| Jun 1995 | $7.60 M(+76.7%) | $7.60 M(+72.7%) |
| Mar 1995 | - | $4.40 M(0.0%) |
| Dec 1994 | - | $4.40 M(0.0%) |
| Sep 1994 | - | $4.40 M(+2.3%) |
| Jun 1994 | $4.30 M | $4.30 M(+2.4%) |
| Mar 1994 | - | $4.20 M(0.0%) |
| Dec 1993 | - | $4.20 M(-940.0%) |
| Sep 1993 | - | -$500.00 K |
FAQ
- What is Moderna annual stockholders equity?
- What is the all time high annual shareholders equity for Moderna?
- What is Moderna annual shareholders equity year-on-year change?
- What is Moderna quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Moderna?
- What is Moderna quarterly shareholders equity year-on-year change?
What is Moderna annual stockholders equity?
The current annual shareholders equity of MRNA is $10.90 B
What is the all time high annual shareholders equity for Moderna?
Moderna all-time high annual stockholders equity is $19.12 B
What is Moderna annual shareholders equity year-on-year change?
Over the past year, MRNA annual stockholders equity has changed by -$2.95 B (-21.32%)
What is Moderna quarterly stockholders equity?
The current quarterly shareholders equity of MRNA is $10.90 B
What is the all time high quarterly shareholders equity for Moderna?
Moderna all-time high quarterly stockholders equity is $19.12 B
What is Moderna quarterly shareholders equity year-on-year change?
Over the past year, MRNA quarterly stockholders equity has changed by -$2.95 B (-21.32%)